SIRT3 and metabolic dysfunction-associated steatotic liver disease: Additionally, liraglutide improved NAFLD in HFD-fed mice by increasing mitochondrial synthesis, decreasing ROS generation, and elevating autophagy via the SIRT1/SIRT3 pathway [172].